Altimmune Stock (NASDAQ: ALT) stock price, news, charts, stock research, profile.
You can purchase shares of Altimmune (NASDAQ:ALT) through any online brokerage.
Other companies in Altimmune’s space includes: Tectonic Therapeutic (NASDAQ:TECX), KalVista Pharma (NASDAQ:KALV), 4D Molecular Therapeutics (NASDAQ:FDMT), Valneva (NASDAQ:VALN) and Celcuity (NASDAQ:CELC).
Altimmune has a consensus price target of $22.00.
The stock price for Altimmune (NASDAQ: ALT) is $6.27 last updated October 1, 2024 at 7:13 PM EDT.
There are no upcoming dividends for Altimmune.
Altimmune’s Q3 earnings are confirmed for Tuesday, November 5, 2024.
There is no upcoming split for Altimmune.
Altimmune is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.